Few supplements have enjoyed as long and consistent a marketing campaign as ginkgo biloba. This leaf of the ancient Chinese tree, sold as a standardized extract in every pharmacy and health food store, promises one thing above all: sharper memory and a younger brain. Its global market is estimated at hundreds of millions of dollars annually, and it is one of the best-selling 'brain' supplements in Europe and the United States.
But there is one big problem. When science actually tested this promise, in the largest, longest, and most rigorous studies ever conducted on a memory supplement, ginkgo biloba failed. Not 'mixed results,' not 'more research needed.' A clear, repeated, and independent failure. In this article, we will present the real research, with its full numbers, and explain exactly why we rated ginkgo biloba red in our supplement selector.
What is Ginkgo Biloba?
Ginkgo biloba is an extract derived from the leaves of the ginkgo tree, one of the oldest plant species on Earth. The most common standardized extract used in studies is called EGb 761, and it contains several active compounds:
- Flavonoids (about 24% of the extract), with antioxidant activity.
- Terpene lactones (about 6%), including ginkgolides and bilobalide, which are attributed with effects on blood flow.
- Ginkgolic acids, which are mostly removed in quality extracts due to their toxicity.
The marketing logic is simple: the extract improves cerebral blood flow and protects against oxidative damage, so it should preserve memory. This logic sounds convincing. The problem is that it did not hold up to testing.
The Theoretical Mechanism vs. Biological Reality
At the cellular level, ginkgo does do something. Laboratory studies have shown that the extract dilates small blood vessels, reduces blood viscosity, and neutralizes free radicals. These are real mechanisms. The problem is the logical leap from the test tube to the living human brain.
A slight improvement in blood flow does not necessarily translate to memory preservation. Dementia and Alzheimer's are not simply diseases of 'low blood flow'; they are complex processes of amyloid protein accumulation, tau tangles, neuroinflammation, and neuronal death. A single plant antioxidant simply cannot stop these processes. This is precisely the kind of gap between a 'promising mechanism in a test tube' and a 'clinical outcome in humans' that trips up many supplements, and ginkgo is a prime example.
The Current Evidence
Study 1: The GEM Study from 2008
This is the pivotal study, the Ginkgo Evaluation of Memory, published in the prestigious journal JAMA in November 2008. It is a randomized, double-blind, placebo-controlled trial conducted at five academic centers in the United States. 3,069 volunteers over age 75, some with normal cognition and some with mild cognitive impairment, were randomly assigned to receive 120 mg of ginkgo twice daily or a placebo. The median follow-up was 6.1 years, an exceptionally long and thorough study.
The result was unequivocal. In the ginkgo group, 277 participants developed dementia, compared to 246 in the placebo group. The hazard ratio was 1.12, indicating a slight trend toward harm rather than benefit, with no statistical significance. The researchers concluded in unmistakable terms: ginkgo has no effect on the development of dementia or Alzheimer's.
Study 2: The GuidAge Study from 2012
Those who hoped it might be a local failure received an answer four years later. The GuidAge study, published in Lancet Neurology, was conducted in France on over 2,800 older adults over age 70 who complained of memory problems to their family doctor. Again: 120 mg of ginkgo twice daily vs. placebo, with a follow-up of 5 years.
The result was essentially identical. 61 participants in the ginkgo group were diagnosed with Alzheimer's, compared to 73 in the placebo group, a difference that was not statistically significant. Two massive studies, on different continents, with independent protocols, reached the same conclusion: ginkgo biloba does not prevent dementia.
Study 3: The Cochrane Review from 2009
The Cochrane Review, the gold standard of evidence-based medicine, compiled all randomized trials on ginkgo for cognitive impairment and dementia. The official conclusion: there is no consistent and convincing evidence that ginkgo biloba has significant clinical benefit for people with dementia or cognitive decline. Results in smaller studies were inconsistent and not reproducible, a hallmark of a non-genuine effect.
What About Healthy and Younger People?
Maybe ginkgo doesn't prevent dementia, but does it sharpen memory in a healthy person? Here too, the answer is disappointing. Systematic reviews examining the 'nootropic' effect of ginkgo on healthy individuals found no reliable effect on memory, concentration, or executive function. In short, not only does it not stop cognitive decline, it also doesn't improve performance in those who are perfectly healthy. This is a supplement that promises a lot and delivers almost nothing.
So Why is Ginkgo Biloba Rated Red?
Our red rating is not just about lack of efficacy. A supplement can be useless but safe, and then it would be rated yellow. Ginkgo gets red due to a combination of two problems:
- Lack of proven benefit: As we have seen, the two largest mega-studies and the Cochrane Review refute the product's central promise.
- Real safety risk: Ginkgo is a mild blood thinner. The ginkgolides in the extract inhibit platelet activity (PAF, platelet-activating factor).
The real danger begins with interactions with medications. A person taking anticoagulants like warfarin (Coumadin), aspirin, clopidogrel (Plavix), or direct oral anticoagulants who adds ginkgo increases the risk of bleeding. Cases of spontaneous bleeding, including intracerebral hemorrhage and ocular bleeding, have been described in the literature in connection with ginkgo use. Additionally, it is recommended to stop ginkgo at least two weeks before any surgery due to the bleeding risk.
When you combine these two factors—a product that does not deliver the promised benefit, while simultaneously carrying a real safety risk for the older population that already takes many medications—you get a poor risk-benefit profile. This is exactly the definition of a red rating: do not take it, or at the very least, not without close medical supervision.
What to Take Away from the Research?
- Do not buy ginkgo biloba to improve memory. The evidence from the largest studies clearly says it doesn't work. Your money is wasted.
- If you are taking anticoagulants or aspirin, stay away from ginkgo. The combination is dangerous and can cause bleeding. Consult a doctor before any combination.
- Invest in what truly protects the brain: aerobic physical activity, quality sleep, managing blood pressure and blood sugar, and a Mediterranean diet. These are the interventions with the strongest evidence for cognitive preservation.
- Remember the 'test tube vs. humans' principle: A nice mechanism in the lab is no guarantee of a real outcome. Always look for large randomized human trials.
If you still wish to personally try the product after medical consultation, you can purchase ginkgo biloba on iHerb. To find evidence-based supplements with a green rating for improving brain function, try our personal supplement selector.
The Broader Perspective
The story of ginkgo biloba is a perfect lesson in the logic of science versus marketing. For decades, a memory supplement was sold based on a convincing theoretical mechanism, until one large, rigorous study, GEM, shattered the entire deck. This didn't happen because the researchers were cynical, but because that's how science works: a nice hypothesis remains a hypothesis until it is put to a randomized, double-blind test.
The important lesson for anyone seeking longevity and brain health is this: Beware of promises that rely on a 'mechanism' rather than an 'outcome'. Ginkgo biloba was supposed to work, it sounded like it should work, but it simply doesn't work. If the best science we have says 'no,' that word is worth more than any advertisement.
References:
DeKosky ST, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial (GEM Study). JAMA, 2008. DOI: 10.1001/jama.2008.683
Vellas B, et al. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge). Lancet Neurology, 2012.
Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, 2009.
💬 תגובות (0)
היו הראשונים להגיב על המאמר.